These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. AKAP-Lbc: a molecular scaffold for the integration of cyclic AMP and Rho transduction pathways. Diviani D; Baisamy L; Appert-Collin A Eur J Cell Biol; 2006 Jul; 85(7):603-10. PubMed ID: 16460837 [TBL] [Abstract][Full Text] [Related]
4. RGS2 is upregulated by and attenuates the hypertrophic effect of alpha1-adrenergic activation in cultured ventricular myocytes. Zou MX; Roy AA; Zhao Q; Kirshenbaum LA; Karmazyn M; Chidiac P Cell Signal; 2006 Oct; 18(10):1655-63. PubMed ID: 16517124 [TBL] [Abstract][Full Text] [Related]
5. AKAP-Lbc mediates protection against doxorubicin-induced cardiomyocyte toxicity. Caso S; Maric D; Arambasic M; Cotecchia S; Diviani D Biochim Biophys Acta Mol Cell Res; 2017 Dec; 1864(12):2336-2346. PubMed ID: 28923249 [TBL] [Abstract][Full Text] [Related]
16. The alpha1-adrenergic receptors in cardiac hypertrophy: signaling mechanisms and functional implications. Cotecchia S; Del Vescovo CD; Colella M; Caso S; Diviani D Cell Signal; 2015 Oct; 27(10):1984-93. PubMed ID: 26169957 [TBL] [Abstract][Full Text] [Related]
17. Role of endothelin-1, sodium hydrogen exchanger-1 and mitogen activated protein kinase (MAPK) activation in glucose-induced cardiomyocyte hypertrophy. Chen S; Khan ZA; Karmazyn M; Chakrabarti S Diabetes Metab Res Rev; 2007 Jul; 23(5):356-67. PubMed ID: 17024690 [TBL] [Abstract][Full Text] [Related]
18. UCR1C is a novel activator of phosphodiesterase 4 (PDE4) long isoforms and attenuates cardiomyocyte hypertrophy. Wang L; Burmeister BT; Johnson KR; Baillie GS; Karginov AV; Skidgel RA; O'Bryan JP; Carnegie GK Cell Signal; 2015 May; 27(5):908-22. PubMed ID: 25683917 [TBL] [Abstract][Full Text] [Related]